Swedish Orphan Biovitrum AB (publ)
LSE:0MTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swedish Orphan Biovitrum AB (publ)
LSE:0MTD
|
SE |
|
S
|
Sino Land Co Ltd
F:SNO
|
HK |
|
V
|
Varex Imaging Corp
SWB:VI4
|
US |
|
N
|
Nano Dimension Ltd
F:2N5B
|
IL |
|
Ringkjoebing Landbobank A/S
F:CJ2
|
DK |
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
IL |
|
G
|
Gildan Activewear Inc
F:VGA
|
CA |
|
N
|
Neogenomics Inc
SWB:NG9
|
US |
|
H
|
Hikari Tsushin Inc
XBER:HIK
|
JP |
|
NexPoint Residential Trust Inc
F:5O4
|
US |
|
B
|
Bruker Corp
F:BKD
|
US |
|
H
|
Hain Celestial Group Inc
F:HF1
|
US |
Wall St Price Targets
0MTD Price Targets Summary
Swedish Orphan Biovitrum AB (publ)
According to Wall Street analysts, the average 1-year price target for 0MTD is 472.84 SEK with a low forecast of 309.4 SEK and a high forecast of 574.38 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0MTD's stock price target?
Price Target
472.84
SEK
According to Wall Street analysts, the average 1-year price target for 0MTD is 472.84 SEK with a low forecast of 309.4 SEK and a high forecast of 574.38 SEK.
What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
600%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 600%.
What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
43%
The compound annual growth rate for Net Income over the next 8 years is 43%.
